Recent preclinical results indicate novel next-generation vaccine candidates developed at Cleveland Clinic protect against multiple strains of influenza and last longer than vaccines currently in use.
Greenlane Announces Board’s Approval of Reverse Stock Split Ratio
BOCA RATON, FL / ACCESSWIRE / June 2, 2023 / Greenlane Holdings, Inc. (NASDAQ:GNLN) (“Greenlane”), one of the largest global sellers of premium cannabis accessories,